Despite weak Q3 earnings, Bharat Petroleum (BPCL) draws attention from global brokerages. CLSA upgraded BPCL to ‘Hold with a ...

The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially ...

This steady growth in HDFC Bank's core earnings - both NII and net profit - came in despite a marginal rise in NPAs and NPA ...

CLSA has initiated coverage on Hyundai Motor India with an 'Outperform' rating and a target price of Rs 2,155, citing strong ...

The brokerage firm has also added Zomato to its high conviction outperform list, saying the recent correction is a buying ...

On Thursday, Coupang Inc (CPNG) stock saw a decline, ending the day at $22 which represents a decrease of $-0.25 or -1.12% from the prior close of $22.25. The stock opened at $22.18 and touched a low ...

Healthcare stocks see mixed performance as Dr Lal Pathlabs and Aurobindo Pharma rise over 2% after CLSA upgrades their ...

CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from INR1,140 to INR1,090 ...

This is the first time Indus Towers has received a ₹575 target, making it the highest among analysts covering the telecom ...

India's most valued company, Reliance Industries Ltd (RIL), reported a robust performance in the third quarter of the current ...

HCLTech declared a dividend of Rs 18 per share, including a special Rs 6 per share dividend to commemorate 25 years since its ...